ProNeurogen
  • Home
  • About Leadership Board of Directors Business Advisory Board Scientific Advisory Board
  • What is Vascular Dementia Angiotensin- (1-7) Peptides
  • PIPELINE Opportunity Competition Patent Portfolio
  • News
  • Contact
ProNeurogen
  • Home/
  • About/
    • About
    • Leadership
    • Board of Directors
    • Business Advisory Board
    • Scientific Advisory Board
  • Technology/
    • What is Vascular Dementia
    • Angiotensin- (1-7) Peptides
  • Opportunity/
    • PIPELINE
    • Opportunity
    • Competition
    • Patent Portfolio
  • News/
  • Contact/
pipeline wave.jpg
ProNeurogen

HARNESSING THE NATURAL POWER OF PEPTIDES TO TREAT VASCULAR DEMENTIA

PIPELINE

ProNeurogen
  • Home/
  • About/
    • About
    • Leadership
    • Board of Directors
    • Business Advisory Board
    • Scientific Advisory Board
  • Technology/
    • What is Vascular Dementia
    • Angiotensin- (1-7) Peptides
  • Opportunity/
    • PIPELINE
    • Opportunity
    • Competition
    • Patent Portfolio
  • News/
  • Contact/

PRONEUROGEN THERAPEUTIC PLATFORM PIPELINE

WE ARE DEVELOPING A PLATFORM OF DRUG CANDIDATES THAT HAVE THE POTENTIAL TO IMPROVE PATIENT’S LIVES BY TARGETING THE UNDERLYING CAUSES OF VASCULAR AND MIXED DEMENTIA. 

©ProNeurogen 2024 All rights reserved.